Yasenchak, C: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

1

High-throughput engineering of the mouse genome coupled with high-resolution expression analysis

Valenzuela, David M, Murphy, Andrew J, Frendewey, David, Gale, Nicholas W, Economides, Aris N, Auerbach, Wojtek, Poueymirou, William T, Adams, Niels C, Rojas, Jose, Yasenchak, Jason

Journal:

Nature Biotechnology

Year:

2003

Language:

english

File:

PDF, 1.22 MB

english, 2003

2

Synthesis of 7,8,9,10-tetrahydropyrido[3′,4′:4,5]pyrrolo[2,3-c]quinolines

Karl Schönafinger, Christine M. Yasenchak, Anne Vollman, Helen H. Ong

Journal:

Journal of Heterocyclic Chemistry

Year:

1988

File:

PDF, 235 KB

1988

3

Delayed rRNA Processing Results in Significant Ribosome Biogenesis and Functional Defects

Meskauskas, A., Baxter, J. L., Carr, E. A., Yasenchak, J., Gallagher, J. E. G., Baserga, S. J., Dinman, J. D.

Journal:

Molecular and Cellular Biology

Year:

2003

Language:

english

File:

PDF, 473 KB

english, 2003

4

A low-literacy skin care manual for spinal cord injury patients

Patricia A. Yasenchak, Mary J. Bridle

Journal:

Patient Education and Counseling

Year:

1993

Language:

english

File:

PDF, 470 KB

english, 1993

5

Agouti-related protein-deficient mice display an age-related lean phenotype

Katherine E. Wortley, Keith D. Anderson, Jason Yasenchak, Andrew Murphy, David Valenzuela, Sabrina Diano, George D. Yancopoulos, Stanley J. Wiegand, Mark W. Sleeman

Journal:

Cell Metabolism

Year:

2005

Language:

english

File:

PDF, 335 KB

english, 2005

6

Chain scission and anti fungal effect of electron beam on cellulose membrane

Pikul Wanichapichart, Wirach Taweepreeda, Safitree Nawae, Pastraporn Choomgan, Dan Yasenchak

Journal:

Radiation Physics and Chemistry

Year:

2012

Language:

english

File:

PDF, 912 KB

english, 2012

7

Response to Rituximab in Patients with Type II Cryoglobulinemia

Bryce, Alan H., Dispenzieri, Angela, Kyle, Robert A., Lacy, Martha Q., Rajkumar, S. Vincent, Inwards, David J., Yasenchak, Christopher A., Kumar, Shaji K., Gertz, Morie A.

Journal:

Clinical Lymphoma & Myeloma

Year:

2006

Language:

english

File:

PDF, 111 KB

english, 2006

8

Long-term proteasome inhibition in newly diagnosed multiple myeloma (NDMM): US MM-6, a real-world study transitioning from bortezomib to ixazomib

Yimer, Habte, Rifkin, Robert, Noga, Stephen, Manda, Sudhir, Birhiray, Ruemu, Yasenchak, Christopher, Lyons, Roger, Kelly, Peter, Chojnicki, Eric, Whidden, Presley, Wang, Bingxia, Demers, Brittany, Dol

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2019

File:

PDF, 60 KB

2019

9

RESEARCH ARTICLE: What We Know About the Ubiquitous Brownfield: A Case Study of Two New Jersey Cities and Their Gas Stations

Yasenchak, Leah Benedict

Journal:

Environmental Practice

Year:

2009

Language:

english

File:

PDF, 217 KB

english, 2009

10

Classical Hodgkin Lymphoma Treatment Patterns, Molecular Profiling, and Clinical Outcomes in US Oncology Practices: A Prospective Observational Study

Yasenchak, Christopher, Armand, Philippe, Stevens, Don, Le, Trong Kim, De Solda, Francesco, Samakoglu, Selda, Gajavelli, Srikanth, Svoboda, Jakub

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2018

Language:

english

File:

PDF, 70 KB

english, 2018

11

Cabozantinib for metastatic breast carcinoma: results of a phase II placebo-controlled randomized discontinuation study

Tolaney, Sara M., Nechushtan, Hovav, Ron, Ilan-Gil, Schöffski, Patrick, Awada, Ahmad, Yasenchak, Chris A., Laird, A. Douglas, O’Keeffe, Bridget, Shapiro, Geoffrey I., Winer, Eric P.

Journal:

Breast Cancer Research and Treatment

Year:

2016

Language:

english

File:

PDF, 516 KB

english, 2016

12

An open-label phase 2 trial of entospletinib in indolent non-Hodgkin lymphoma and mantle cell lymphoma

Andorsky, David J., Kolibaba, Kathryn S., Assouline, Sarit, Forero-Torres, Andres, Jones, Vicky, Klein, Leonard M., Patel-Donnelly, Dipti, Smith, Mitchell, Ye, Wei, Shi, Wen, Yasenchak, Christopher A.

Journal:

British Journal of Haematology

Year:

2018

Language:

english

File:

PDF, 209 KB

english, 2018

13

The Upf3 protein is a component of the surveillance complex that monitors both translation and mRNA turnover and affects viral propagation

Ruiz-Echevarria, M. J., Yasenchak, J. M., Han, X., Dinman, J. D., Peltz, S. W.

Journal:

Proceedings of the National Academy of Sciences

Year:

1998

Language:

english

File:

PDF, 243 KB

english, 1998

14

A C-Terminal Deletion Mutant of Pokeweed Antiviral Protein Inhibits Programmed +1 Ribosomal Frameshifting and Ty1 Retrotransposition without Depurinating the Sarcin/Ricin Loop of rRNA

Katalin A. Hudak, Amy B. Hammell, Jason Yasenchak, Nilgun E. Tumer, Jonathan D. Dinman

Journal:

Year:

2001

Language:

english

File:

PDF, 268 KB

english, 2001

15

Precise and in situ genetic humanization of 6 Mb of mouse immunoglobulin genes

Macdonald, L. E., Karow, M., Stevens, S., Auerbach, W., Poueymirou, W. T., Yasenchak, J., Frendewey, D., Valenzuela, D. M., Giallourakis, C. C., Alt, F. W., Yancopoulos, G. D., Murphy, A. J.

Journal:

Proceedings of the National Academy of Sciences

Year:

2014

Language:

english

File:

PDF, 733 KB

english, 2014

16

TREATMENT PATTERNS, CLINICAL OUTCOMES, AND BIOMARKER EVALUATION IN CLASSICAL HODGKIN LYMPHOMA: A PROSPECTIVE OBSERVATIONAL STUDY IN US ONCOLOGY PRACTICES

Svoboda, J., Armand, P., Porcu, P., Burke, J.M., Stevens, D., Moezi, M., Bajaj, M., Cull, E.H., Wan, Y., Duan, C., Forslund, A., Gajavelli, S., Yasenchak, C.

Journal:

Hematological Oncology

Year:

2019

Language:

english

File:

PDF, 262 KB

english, 2019

17

TREATMENT PATTERNS, CLINICAL OUTCOMES, AND BIOMARKER EVALUATION IN CLASSICAL HODGKIN LYMPHOMA: A PROSPECTIVE OBSERVATIONAL STUDY IN US ONCOLOGY PRACTICES

Svoboda, J., Armand, P., Porcu, P., Burke, J.M., Stevens, D., Moezi, M., Bajaj, M., Cull, E.H., Wan, Y., Duan, C., Forslund, A., Gajavelli, S., Yasenchak, C.

Journal:

Hematological Oncology

Year:

2019

File:

PDF, 262 KB

2019

18

Economic impact of disease progression following front-line therapy in classical Hodgkin lymphoma

Yasenchak, Christopher A., Tseng, Wan-Yu, Yap, Mark, Rembert, Debra, Patt, Debra A.

Journal:

Leukemia and Lymphoma

Year:

2015

Language:

english

File:

PDF, 599 KB

english, 2015

19

Results of a Phase 2 Placebo-Controlled Randomized Discontinuation Trial of Cabozantinib in Patients with Non–Small-Cell Lung Carcinoma

Hellerstedt, Beth A., Vogelzang, Nicholas J., Kluger, Harriet M., Yasenchak, Christopher A., Aftab, Dana T., Ramies, David A., Gordon, Michael S., Lara, Primo

Journal:

Clinical Lung Cancer

Year:

2018

Language:

english

File:

PDF, 864 KB

english, 2018

20

Long-term proteasome inhibition in newly diagnosed multiple myeloma (NDMM): US MM-6, a real-world study transitioning from bortezomib to ixazomib

Yimer, Habte, Rifkin, Robert, Noga, Stephen, Manda, Sudhir, Birhiray, Ruemu, Yasenchak, Christopher, Lyons, Roger, Kelly, Peter, Chojnicki, Eric, Whidden, Presley, Wang, Bingxia, Demers, Brittany, Dol

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2019

Language:

english

File:

PDF, 60 KB

english, 2019

21

Tissue response to implanted polymers: The significance of sample shape

Barbara F. Matlaga, Lewis P. Yasenchak, Thomas N. Salthouse

Journal:

Journal of Biomedical Materials Research Part B: Applied Biomaterials

Year:

1976

Language:

english

File:

PDF, 366 KB

english, 1976

22

ChemInform Abstract: Synthesis of 7,8,9,10-Tetrahydropyrido(3′,4′:4,5)pyrrolo(2,3-c)quinolines.

SCHOENAFINGER, K., YASENCHAK, C. M., VOLLMAN, A., ONG, H. H.

Journal:

Year:

1988

File:

PDF, 194 KB

1988

23

The Upf3 Protein is a Component of the Surveillance Complex that Monitors Both Translation and mRNA Turnover and Affects Viral Propagation

Maria J. Ruiz-Echevarria, Jason M. Yasenchak, Xia Han, Jonathan D. Dinman and Stuart W. Peltz

Journal:

Proceedings of the National Academy of Sciences

Year:

1998

Language:

english

File:

PDF, 1.40 MB

english, 1998

24

Frontline brentuximab vedotin in combination with dacarbazine or bendamustine in patients aged ≥60 years with HL

Friedberg, Jonathan W., Forero-Torres, Andres, Bordoni, Rodolfo E., Cline, Vivian J.M., Patel Donnelly, Dipti, Flynn, Patrick J., Olsen, Gregg, Chen, Robert, Fong, Abraham, Wang, Yinghui, Yasenchak, C

Journal:

Year:

2017

Language:

english

File:

PDF, 464 KB

english, 2017

25

Ribosomal Protein L3 Mutants Alter Translational Fidelity and Promote Rapid Loss of the Yeast Killer Virus

Peltz, Stuart W., Hammell, Amy B., Cui, Ying, Yasenchak, Jason, Puljanowski, Lara, Dinman, Jonathan D.

Journal:

Molecular and Cellular Biology

Year:

1999

Language:

english

File:

PDF, 561 KB

english, 1999

26

397 Phase 2 results of XL184 in a cohort of patients (pts) with advanced non-small cell lung cancer (NSCLC)

C. Yasenchak, K. Nackaerts, A. Awada, S.M. Gadgeel, B. Hellerstedt, M.C. Perry, D. Richards, C.H. Yang, C. Scheffold, P.N. Lara Jr.

Journal:

European Journal of Cancer Supplements

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

27

An open-label phase 2 trial of entospletinib (GS-9973), a selective spleen tyrosine kinase inhibitor, in chronic lymphocytic leukemia

Sharman, J., Hawkins, M., Kolibaba, K., Boxer, M., Klein, L., Wu, M., Hu, J., Abella, S., Yasenchak, C.

Journal:

Year:

2015

Language:

english

File:

PDF, 1.12 MB

english, 2015

28

LONG-TERM PROTEASOME INHIBITION (LTPI) IN PATIENTS (PTS) WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): US MM-6, A REAL-WORLD (RW) STUDY TRANSITIONING FROM BORTEZOMIB (BTZ) TO IXAZOMIB (IXA)

Rifkin, R. M., Yimer, H. A., Noga, S. J., Manda, S., Birhiray, R., Yasenchak, C., Lyons, R., Kelly, P., Chojnicki, E., Whidden, P., Wang, B., Demers, B., Dollar, L., Boccia, R.

Journal:

Year:

2019

File:

PDF, 255 KB

2019

29

Client Perceptions of the Ideal Addictions Counselor

Rohrer, Glenn E., Thomas, Melville, Yasenchak, Amy B.

Journal:

Substance Use & Misuse

Year:

1992

Language:

english

File:

PDF, 264 KB

english, 1992

30

Feasibility of Long-term Proteasome Inhibition in Multiple Myeloma by in-class Transition From Bortezomib to Ixazomib

Manda, Sudhir, Yimer, Habte A., Noga, Stephen J., Girnius, Saulius, Yasenchak, Christopher A., Charu, Veena, Lyons, Roger, Aiello, Jack, Bogard, Kimberly, Ferrari, Renda H., Cherepanov, Dasha, Demers,

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2020

File:

PDF, 579 KB

2020

31

Protein-tyrosine Phosphatase H1 Controls Growth Hormone Receptor Signaling and Systemic Growth

Pilecka, Iwona, Patrignani, Claudia, Pescini, Rosanna, Curchod, Marie-Laure, Perrin, Dominique, Xue, Yingzi, Yasenchak, Jason, Clark, Ann, Magnone, Maria Chiara, Zaratin, Paola, Valenzuela, David, Rom

Journal:

Journal of Biological Chemistry

Year:

2007

Language:

english

File:

PDF, 1.17 MB

english, 2007

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски